Industry

Avvio Medical’s Microbubble Technology Reduces Complications and Shows Promise for Enhancing Laser Lithotripsy: AEROLITH Trial Results Published in The Journal of Urology

SAN FRANCISCO–(BUSINESS WIRE)–Avvio Medical Inc. today announced the publication of its AEROLITH randomized clinical trial in The Journal of Urology. Study highlights were presented at the 2025 American Urological Association (AUA) Annual Meeting in Las Vegas, Nevada. The AEROLITH study evaluated the safety and effectiveness of Acoustic Enhancer Microbubble Cavitation (AEMC) when used with ureteroscopic … [Read more…]

Vertex to Announce Second Quarter 2025 Financial Results on August 4th

BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2025 financial results on Monday, August 4, 2025 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the “Vertex … [Read more…]

The Ngāi Tahu Research Centre Has Entered Into a Strategic Partnership With De-Extinction Company, Colossal Biosciences, and Sir Peter Jackson, to Resurrect the South Island Giant Moa and Other Taonga Species

The Ngāi Tahu Research Centre coordinated project aims to advance ecological restoration and develop tools for conservation in Te Waipounamu, New Zealand’s South Island TE WAIPOUNAMU/SOUTH ISLAND, New Zealand–(BUSINESS WIRE)–In a historic indigenous-coordinated initiative, the Ngāi Tahu Research Centre has entered into a collaboration with Colossal Biosciences, a Texas-based genetic engineering and de-extinction company, and … [Read more…]

SBB Research Group Foundation Awards Additional Grants to 3 Illinois Nonprofits

CHICAGO–(BUSINESS WIRE)–The SBB Research Group Foundation invited three prior grant recipients to share updates on their critical efforts to support the local community. The Foundation awarded additional grants to further each of the respective organizations’ missions (organizations listed alphabetically): Black Onyx Allstars (Chicago, IL) offers a culturally inclusive and empowering cheerleading experience that fosters community … [Read more…]

WELL Health Provides Corporate Update on Canadian Clinics Business, Reflecting Improved Guidance and an Expanded Credit Facility

WELL continues to demonstrate strong momentum through continued organic and inorganic growth and is pleased to announce that it is ahead of internal expectations and has updated its guidance for its Canadian Patient Services segment to over $450 million(1) in revenue and over $60 million(1) in Adjusted EBITDA(2) for fiscal 2025. WELL’s Canadian Clinics business … [Read more…]

BlueRock Therapeutics announces first patient receives investigational therapy in Phase 1/2a clinical trial of OpCT-001 for the treatment of primary photoreceptor diseases

OpCT-001 is the first iPSC-derived investigational cell therapy to be clinically tested for treating primary photoreceptor diseases Phase 1/2a trial, CLARICO, is a first-in-human, multisite, 2-part interventional trial to evaluate the safety, tolerability, and the effect on clinical outcomes of OpCT-001 Primary photoreceptor diseases are a subgroup of inherited retinal disorders that affect the structure … [Read more…]

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial

SAN DIEGO–(BUSINESS WIRE)–#invivoscribe–Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Through this collaboration, LabPMM (Invivoscribe’s global reference laboratories) have customized their multiparametric … [Read more…]

UK MHRA Approves ImmunityBio’s ANKTIVA® Plus BCG for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In Situ

ANKTIVA, a first-in-class, lymphocyte-stimulating agent, works synergistically with BCG to activate and proliferate natural killer (NK) and T cells, helping eliminate cancer Already approved in the U.S. and designated as a Breakthrough Therapy by the FDA, this marks ANKTIVA’s first marketing approval outside the U.S. ANKTIVA plus BCG offers a new option for eligible patients … [Read more…]

BioSig Technologies, Inc. and Streamex Exchange Corporation Announce Definitive Agreements for up to $1.1B USD in Growth Financing to Launch Gold Backed Treasury Management Strategy and to Rapidly Expand RWA Tokenization for the Commodities Markets

BioSig Technologies, Inc. (Nasdaq: BSGM), which recently merged with Streamex Exchange Corporation (“Streamex”) to become one of largest public holders of gold bullion. Streamex’ proprietary real-world asset (the “RWA”) platform will bring the approx. $142 trillion commodities market on the blockchain powered by Streamex & Solana. The transaction was led by: Cantor Fitzgerald & Co., … [Read more…]

Inverness Graham-backed Innovia Medical Completes Two Strategic Acquisitions, Establishes Leading Manufacturer of ENT and Ophthalmic Surgical Products

WAYNE, Pa.–(BUSINESS WIRE)–Inverness Graham, a Philadelphia-based buyout firm focused on acquiring innovative companies where technology is transforming traditional industry, announced today that its single-use surgical products manufacturer, Innovia Medical (“Innovia”), has closed on two strategic acquisitions in Grace Medical and Hurricane Medical. These transformative acquisitions accelerate Innovia’s strategic vision of building a vertically integrated manufacturer … [Read more…]